synthetic high purity caso -...
TRANSCRIPT
SYNTHETIC HIGH PURITY CaSO4
Stimulan® implant grade calcium sulphate is a synthetic biocompatiblebone graft material that completely resorbs, to be replaced by newbone. It has a rate of resorption that corresponds with the rate ofnew bone growth.
Stimulan® calcium sulphate is produced using a proprietarysynthetic process# ensuring consistent and reproducible results.The physical and chemical properties are tightly controlled with notraces of potentially toxic impurities, which have been associatedwith naturally occurring mineral sources of calcium sulphate.
Stimulan® represents a major breakthrough in resorbable bonegraft technology. In terms of purity and consistency, it is unrivalledby virtue of its unique and proprietary process, which has beendeveloped by Biocomposites’ biomaterial development team overyears of careful, in-depth research.
AVAILABLE IN 3 FORMS
PELLETSAbsorbable pellets for open procedure
PERCUTANEOUS DISPENSERFor minimally invasive procedure
INJECTABLE PASTEFully setting paste with individual pelletising kit
# International Patents Pending
BONE GRAFTING THE FUTURE
page 2
The Case for Synthetic Bone Substitutes
Autograft
Autograft availability is limited and its harvesting, usually from the iliaccrest, increases surgery time, can prolong hospital stay and very oftenresults in donor site morbidity.
“...tissue banks vary in complexity and scope of operation anddepend on a variety of techniques in the selection of donors andthe exclusion and preparation of bone and tissue allografts...”
“...therefore it behoves orthopaedic surgeons to find outspecifically how the allografts they are about to use were excisedand prepared...”
“...irradiation clearly alters biomechanical properties of collagen,hence bone structure, and diminishes its osteoinductive potential...”
Extracts taken from - Bone Loss in Revision Surgery: How to Manage the Femoral Side.
C.A. Engh, Sr., W.C. Head, A.G. Rosenberg, F.H. Sim
American Academy of Orthopaedic Surgeons 68th Annual Meeting, 2001.
AllograftGalea et al stated that the source from bone banks cannot meetthe demand for the increasing incidence of revision surgery.
J Bone Joint Surgery (Br) Vol. 80-B No. 4, July 1998
Palmer et al referred to their findings of pathological lesions presentin osteoarthritic femoral heads; unknown to both the patient andthe medical staff.
J Bone Joint Surgery (Br) Vol. 81-B No. 2, March 1999
Bone grafting techniques have been widely used in orthopaedicsurgery and bone is the second most frequently transplantedmaterial after blood. Bone grafts are increasingly used to fill bonecavities resulting from disease, trauma or surgery and also to fusejoints and non-unions.
Specification of Stimulan®
Comparison Table - Competitor Products
Nd Not detected
* The earth mineral, dolomite
** Aggregate, or “earth impurities” are present in calcium sulphate sourced from mined
gypsum rock. They are non-bioabsorbable and can include such elements as feldspar, clay and crystalline
silica (quartz)
Controlled phase purity ensures consistent resorption
Higher chemical purity ensures total biocompatibility
The resorption rate is consistent with the formationof new bone
Safe to use even in infected cases
Key advantages to the Surgeon
Stimulan® productgeometry and form
Presentation to surgical siteCalcium sulphatechemical form
Injectable, mouldable,setting paste
Dispenser for percutaneous,minimally invasive
implantation or in jars
Hemihydrate
Di-hydrate
Powder andmixing solution
Preformed, uniformpellets
Phase analysis
CaSO4 2H2O
CaCO3MgCO3*
CaCO3
Aggregate**
Commercialcalcium sulphate
80-94%>
5.1%
1.0%
4.5%
Medical/surgicalgrade
98%>
0.5%
0.3%
0.3%
Stimulan®
implant grade
100%
Nd
Nd
Nd
SpecificationCharacteristic
Chemical
Physical
Purity
CaSO4 2H2O
Regular pellets or injectable setting paste
100%
page 3
TECHNICAL PROFILE
BONE REGENERATION THE EVIDENCE
page 4
Figure 1
Trabecular bone interspersed with healthy bone marrow - sheep study
In-vitro Studies - Scanning electron micrograph showing human osteoblasts growing onsurface of Stimulan® at 21 days
In-Vitro Studies - Stimulan®
In-Vivo Studies - Stimulan®
Stimulan® calcium sulphate pellets were implanted into a sheep’s
epiphyseal humerus.
Radiographic examination 6 weeks after implantation shows no
evidence of the pellets, indicating complete resorption
Trabecular bone can be clearly seen interspersed with healthy bone
marrow (Figure 1) and osteoblast activity is much in evidence (Figure 2).
Figure 2
Osteoblasts at 6 weeks in a sheep model
Stimulan® Calcium Sulphate
Osteoblast
Stimulan® Calcium Sulphate
Trabecular Bone
Bone Marrow
Osteoblasts
* Full data available on request from Biocomposites
Single cell layer ofosteoblasts on surfaceof new bone - indicatingremodelling activity
Newly formedtrabecular bone
page 5
CASE STUDYMA/SK090106
53 year old male sustained comminuted distaltibial fracture
Normal physiologic absorption of CaSO4 occurs with thesimultaneous deposition of autogenous cancellous bone
Andries S. Coetzee, Mmed (ORL) Arch Otolaryngol-Vol.106, July 1980
Calcium Sulphate is the material of choice when infectionis present or anticipated
Leonard F. Peltier, M.D. Professor of Surgery, University of Kansas Medical Centre, Kansas City,
Kansas - The Use of Plaster of Paris to Fill Defects in Bone, Clin Orthop 21-31, 1961
Stimulan® placed usingposterior approach withdecortication andreconstruction of articularsurface
8 weeks post op showingadvanced resorptionwith healing and callusformation
18 months post opshowing total resorptionand advanced healing
Reduction of ankle fracture fragments was achieved using Stimulan®
to maintain space and promote ingrowth of new bone
Indications Pot Size/Dosage
Catalogue RefDiaDispenser/Cannula
Spinal Fusion
Trauma
Benign Cystic Lesions
Revision Surgery
Diabetic Foot
3.0mm
4.8mm
5cc
10cc
10cc
20cc
600-30-005
600-30-010
600-48-010
600-48-020
Absorbable pellets for openprocedure
SYNTHETIC HIGH PURITY CaSO4
PelletsCLINICAL EVIDENCE
Calcium Sulphate is an outstanding bone substitute ensuring boneformation and gives results comparable with autogenous bone
Andries S. Coetzee, Mmed (ORL) Arch Otolaryngol-Vol.106, July 1980
page 6
CASE STUDYMA/SK100106
10 year old male with femoral cyst
Femoral cyst below the lesser trochanter, previous treatment of thecyst involved cortisone injections. However, the hole left by theneedle in the cortex caused the femur to fracture.
Fracture was treated with Stimulan® pellets placed percutaneously.
The patient was reviewed at 14 weeks and the X-rays showcomplete resorption and new bone formation.
Femoral cyst, 10 year old malePrevious treatment failed
Intra-operative placement ofStimulan® using dispensers
14 week follow up showingtotal resporption and newbone formation
ProductsPot Size/Dosage Catalogue RefDia
Dispenser/Cannula
Stimulan® Dispensers 3.0mm
4.8mm
1.5cc
5cc
3mm
4.8mm
600-30-s1
600-48-s1
650-C3
650-C2
650-001Sterilisation Tray
SYNTHETIC HIGH PURITY CaSO4
Dispenser
Percutaneous dispenser (1.5cc & 5cc)
for minimally invasive procedure
Stimulan® Instrument Set
Cannulas instrumentation set to aiddispenser insertion
CLINICAL EVIDENCE
page 7
CASE STUDYMA/SK170106
80 year old male with spinal stenosis
Fusion of Lumbar vertebral interbodies (L2-L5) was achieved usingStimulan® in combination with autograft
ProductPot Size/Dosage Catalogue RefDia
Dispenser/Cannula
Stimulan® Kit 5cc 600-005
Fully setting injectable pastewith individual pelletising kit
SYNTHETIC HIGH PURITY CaSO4
Kit
An injectable and mouldable matrix which sets at body temperatureand fully resorbs to be remodelled by new bone.
Pack Contents Disposable
• CaSO4 • Pre-measured mixing solution bulbs • Syringe• 8cm Extension Tube • Pellet Mould • Spatula
Stimulan® Preparation Protocol for Syringe Injection
Post-opStimulan® placed in combination withautograft
9 months post-opTotal resorption of Stimulan®. New bonegrowth and fusion of Lumbar Vertebrae.L2-L5.
CLINICAL EVIDENCE
10cc 600-010
Step 1 Step 2 Step 3 Step 4 (i) Step 4 (ii)
Step 1 Empty powder into a sterile mixing bowl.
Step 2 Slowly add mixing solution from both bulbs. (If application to pellet mould with spatula is preferred, use contents of large bulb only)
Step 3 Mix thoroughly until a smooth paste is formed (approximately 30 seconds).
Step 4 (i) Backfill the syringe with the paste. Attach the extender tube if required.
(ii) The paste can then be injected into the surgical site.
Please note the kit starts to set hard 3 minutes after mixing and will becomedifficult to draw through the syringe after this time.
Step 5 Allow digitally packed or injected paste to cure undisturbed for 15 minutes after mixing prior to closure.
page 8
BIBLIOGRAPHY
M R Urist:Bone Transplants and Implants, In: Fundamental and Clinical Bone Physiology(Urist M R Editor) pp 331-368, 1980
L F Peltier, D P Speer: Calcium Sulphate. In: Bone Grafts and Bone Substitutes(M B Habal and A H Reddi, eds) pp. 243-251, 1993
A S Coetzee:Regeneration of Bone in the Presence of Calcium Sulphate. Arch. Otolaryngol.106: 405-409, 1980
D Robinson, D Alk, J Sandbank, R Farber, N Halperin:Dept. of Orthopaedics, Assaf Harofe Medical Centre, Zefferin, Israel.Ann Transplant 1999; (3-4):91-7
L F Peltier:The Use of Plaster of Paris to Fill Large Defects in Bone.Am. J. Surg 97(3): 311-315,1959
I S DeWet, C Jansen:The Use of Plaster of Paris to Fill Large Defects in Bone.South African J. Surg. 11: 1-8, 1973
W R Walsh PhD, P Morberg MD PhD, Y Yu PhD, J L Yang PhD,W Haggard PhD, P C Sheath MBBS, M Svehla PhD, W J M Bruce MBBS:Response of a Calcium Sulfate Bone Graft Substitute in a Confined CancellousDefect. Clinical Orthopaedics and related research, 406: pp. 228-236, 2003
R Mirzayan MD, V Panossian MD, R Avedian BS, D M ForresterMD, L R Menedez MD:The Use of Calcium Sulfate in the Treatment of Benign Bone Lesions –a Preliminary Report JBJS vol. 83-A No. 3 March 2001
D G Armstrong et al:The Use of Absorbable Antibiotic-impregnated Calcium Sulphate Pellets in theManagement of Diabetic Foot Infections. Diabetics UK, Diabetics Medicine vol.18 pp 937-943, 2001
R Strocchi et al:Bone Regeneration with Calcium Sulphate: Evidence for Increased Angiogenesisin Rabbits. Journal of Oral Implantology vol. 28 no. 6 pp 273-278, 2002
A G Hadjipavlou MD, J W Simmons MD, J Yang MD, C L Nicodemus PhD,O Esch MD, D J Simmons PhD:Plaster of Paris as an Osteoconductive Material for Interbody Vertebral Fusion inMature Sheep. Spine vol. 25 no. 1 pp 10-16, 2000
T A Wichelhaus et al:Elution Charateristics of Vancomycin, Teicoplanin, Gentamycin and Clindamycinfrom Calcium Sulphate Beads. Journal of Antimicrobial Chemotherapy, 2001
B Meng-Hai et al:An Implant of a composite of Bovine Bone Morphogenetic Protein and Plasterof Paris for Treatment of Femoral Shaft Nonunions. Int Surg,81:pp 390-392, 1996
www.biocomposites.com
INTERNATIONAL
Keele Science Park, Keele, Staffordshire,
England. ST5 5NL
Telephone: +44 (0)1782 338580
Facsimile: +44 (0)1782 338599
E-Mail: [email protected]
U.S.A.
PO Box 2692, Wilmington,
NC 28402
Telephone: +01 910 350 8015
Facsimile: +01 910 350 8072
E-Mail: [email protected]
CHINA SHANGHAI
+86 (0) 21 6380 2385+86 (0) 21 6380 [email protected]
B702360 200070